- Home
- ACON vs CELZ Comparison
ACON vs CELZ Comparison
Compare ACON & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACON
- CELZ
- Stock Information
- Founded
- ACON 2008
- CELZ 1998
- Country
- ACON United States
- CELZ United States
- Employees
- ACON N/A
- CELZ N/A
- Industry
- ACON Retail: Computer Software & Peripheral Equipment
- CELZ Biotechnology: Pharmaceutical Preparations
- Sector
- ACON Technology
- CELZ Health Care
- Exchange
- ACON Nasdaq
- CELZ Nasdaq
- Market Cap
- ACON 4.8M
- CELZ 5.5M
- IPO Year
- ACON 2022
- CELZ N/A
- Fundamental
- Price
- ACON $6.48
- CELZ $2.18
- Analyst Decision
- ACON Buy
- CELZ
- Analyst Count
- ACON 2
- CELZ 0
- Target Price
- ACON $481.00
- CELZ N/A
- AVG Volume (30 Days)
- ACON 18.4K
- CELZ 30.8K
- Earning Date
- ACON 05-15-2025
- CELZ 05-09-2025
- Dividend Yield
- ACON N/A
- CELZ N/A
- EPS Growth
- ACON N/A
- CELZ N/A
- EPS
- ACON N/A
- CELZ N/A
- Revenue
- ACON $54,601.00
- CELZ $14,000.00
- Revenue This Year
- ACON $212.31
- CELZ N/A
- Revenue Next Year
- ACON N/A
- CELZ N/A
- P/E Ratio
- ACON N/A
- CELZ N/A
- Revenue Growth
- ACON N/A
- CELZ 55.56
- 52 Week Low
- ACON $6.20
- CELZ $1.69
- 52 Week High
- ACON $3,499.51
- CELZ $6.90
- Technical
- Relative Strength Index (RSI)
- ACON 34.00
- CELZ 55.59
- Support Level
- ACON $6.50
- CELZ $1.93
- Resistance Level
- ACON $7.18
- CELZ $2.02
- Average True Range (ATR)
- ACON 0.37
- CELZ 0.10
- MACD
- ACON 1.22
- CELZ 0.03
- Stochastic Oscillator
- ACON 14.50
- CELZ 86.21
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.